Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab intravitreal injection plus laser versus laser alone in Coats disease
2018-003863-67Phase 3Active
- Sponsor
- Adolphe de Rothschild Foundation Hospital
- Start
- Nov 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bevacizumab in Coats disease (2 arms), sponsored by Adolphe de Rothschild Foundation Hospital. Started Nov 2018; status: active.
02
Drugs
bevacizumab
03
Conditions
Coats disease
Beyond the preview
Go deeper on 2018-003863-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003863-67.